TearScience develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of Meibomian gland Dysfunction, also known as Dry eye disease. LipiView Ocular Surface uses Interferometry to measure the thickness of the tear film oily lipid layer and LipiFlow Thermal Pulsation System uses heat and pressure to unblock obstructed Meibomian glands to reduce dry eye symptoms.

Type
Private
HQ
Morrisville, US
Founded
2005
Size (employees)
62 (est)-4%
TearScience was founded in 2005 and is headquartered in Morrisville, US
Report incorrect company information

Key People/Management at TearScience

Steve Grenon

Steve Grenon

VP, Research & Development
Diethart Reichardt

Diethart Reichardt

SVP - European Region
Doug Pinotti

Doug Pinotti

GM, Asia Pacific & Latin America
Donald Korb

Donald Korb

CTO & Co - Founder
Wade Hampton

Wade Hampton

Chief Commercial Officer

TearScience Office Locations

TearScience has an office in Morrisville
Morrisville, US (HQ)
250 5151 McCrimmon Pkwy
Show all (1)
Report incorrect company information

TearScience Financials and Metrics

Summary Metrics

Founding Date

2005

Total Funding

$148.9 m

Latest funding size

$19.23 m

Time since last funding

2 years ago

Investors

TearScience's latest funding round in April 2016 was reported to be $19.2 m. In total, TearScience has raised $148.9 m
Report incorrect company information

TearScience News and Updates

Dry Eye Syndrome Treatment Market, by Product Type, Disease Type and Distribution Channel - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

Dry Eye Syndrome Treatment Market, report categorizes the report by Product Type, Disease Type and Distribution Channel. It provides information about - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025 Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information